missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ RPMI 1640 Medium, GlutaMAX™ Supplement

Originally developed to culture human leukemic cells in suspension and as a monolayer

£182.00 - £291.00

Requires: Supplementation


Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
10174603
View Documents
Gibco™
61870143
5L
£182.00
Each
View alternative products
Save Up to 
»
Estimated Shipment: 30-06-2021
Please to purchase this item. Need a web account? Register with us today!
15161513
View Documents
Gibco™
61870150
10L
£291.00
Pack of 10
View alternative products
Save Up to 
»
In stock, ready to ship: 1
Please to purchase this item. Need a web account? Register with us today!
Description

Description

RPMI 1640 Medium (Roswell Park Memorial Institute 1640 Medium) has since been found suitable for a variety of mammalian cells, including HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas.

  • Modified as follows: with GlutaMAX™, phenol red; without HEPES
  • Contains reducing agent glutathione and high concentrations of vitamins
  • Contains biotin, vitamin B12, and PABA, which are not found in Eagle's Minimal Essential Medium or Dulbecco's Modified Eagle Medium
  • Vitamins inositol and choline are present in high concentrations
  • GlutaMAX supplement minimizes toxic ammonia build-up and improves cell viability and growth in an easy-to-use format
  • Contains no proteins, lipids, or growth factors
  • Requires supplementation, commonly with 10% Fetal Bovine Serum (FBS)
  • Uses sodium bicarbonate buffer system (2.0g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH

Antibody and Cell Culture Production, Bioproduction, Cell Culture, Mammalian Cell Culture

Order Info

Shipping Condition: Room Temperature

SDS
Product Certifications

Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law. Customers using Gibco RPMI 1640 in a manufacturing process, who have a submission with the FDA, may request a letter of authorization from Life Technologies to reference their Type II Drug Master File (DMF).